{"DataElement":{"publicId":"6464905","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Version 5.0 Low Level Term MeDRA Text","preferredDefinition":"A text field that represents any unfavorable or unintended symptom, sign, or disease including an abnormal laboratory finding) temporally associated with the use of a medical treatment or procedure that may or may not be considered related to the medical treatment or procedure (adverse event),using terminology from the Medical Dictionary for Regulatory Affairs (MedDRA) version 5.0.","longName":"CTCAE5_LLTMEDDRA_TXT","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2943909","version":"2","preferredName":"Adverse Event Common Terminology Criteria for Adverse Events Term","preferredDefinition":"Text term to represent the Common Terminology Criteria for Adverse Events preferred name for an adverse event.","longName":"AE_CTCAE_TRM","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2747485","version":"1","preferredName":"Common Terminology Criteria for Adverse Events Term","preferredDefinition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.:A word or expression used for some particular thing.","longName":"C49704:C45559","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Terminology Criteria for Adverse Events","conceptCode":"C49704","definition":"A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Term","conceptCode":"C45559","definition":"A word or expression used for some particular thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96B352-8AFA-6D3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"ONEDATA","dateModified":"2008-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAE:Common TerminologyCriteria for Adverse Events","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8D680A5C-2528-3141-E040-BB89AD43657E","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"CURTIST","dateCreated":"2010-08-09","modifiedBy":"BMAESKE","dateModified":"2023-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6464902","version":"1","preferredName":"MedDRA Adverse Event Version 5.0 Low Level Text","preferredDefinition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology._Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s)._A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications._A number with no fractional part, including the negative and positive numbers as well as zero.::5_A response indicating a low level._The words of something written.","longName":"6464902v1.0","context":"Theradex","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6468364","version":"1","preferredName":"MedDRA Adverse Event Version Integer::5 Low Level Text","preferredDefinition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.:Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).:A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.:A number with no fractional part, including the negative and positive numbers as well as zero.::5:A response indicating a low level.:The words of something written.","longName":"6468364v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MedDRA","conceptCode":"C43820","definition":"An international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. The MedDRA Maintenance and Support Services Organization holds a contract with the International Federation of Pharmaceutical Manufacturers Associations to maintain and support the implementation of the terminology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Version","conceptCode":"C25714","definition":"A form or variant of a type or original; one of a sequence of copies of a program, each incorporating new modifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Low Level","conceptCode":"C129476","definition":"A response indicating a low level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"777EFC3F-193B-7C7C-E053-F662850A434D","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-05","modifiedBy":"ONEDATA","dateModified":"2018-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MedDRA v20.0","workflowStatus":"RELEASED","registrationStatus":"Application","id":"777C63FD-D386-0B21-E053-F662850A38EA","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-05","modifiedBy":"HARTLEYG","dateModified":"2019-05-20","changeDescription":"11/8/18 TT released/PClark.; Created to support MedDRA codes for CTCAE v5.0.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"NHLBI","type":"USED_BY","context":"NHLBI"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"MedDRA adverse event code (CT","type":"Preferred Question Text","description":"MedDRA adverse event code (CTCAE v5.0) (derived)","url":null,"context":"Theradex"},{"name":"Specify other:","type":"Alternate Question Text","description":"Specify other:","url":null,"context":"NHLBI"},{"name":"Specify other:","type":"Application Standard Question Text","description":"Specify other:","url":null,"context":"NHLBI"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"MedDRA adverse event code (CTCAE v5.0)","url":null,"context":"COG"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"777CCCC8-89F5-06A9-E053-F662850A6AFA","latestVersionIndicator":"Yes","beginDate":"2018-10-05","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-10-05","modifiedBy":"RODELAA","dateModified":"2019-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}